Pfizer (PFE)

Operating Income Growth

-15.44%

TTM · Period ending:

PFE logo

PFE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-15.44%
PFE TTM Operating Income YoY % (7.45% → -15.44%)
High-resolution chart · PNG

PFE operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pfizer Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
83.0699%
86.6226%
69.2747%
66.1139%
35.7963%
23.9509%
22.6746%
7.7908%
9.7534%
15.8269%
10.8157%
13.1301%
11.8603%
7.4522%
10.8645%
14.5653%
18.7323%
15.8415%
19.2103%
22.4509%
26.2321%
33.0095%
28.3904%
110.1068%
104.365%
66.7949%
72.4063%
-39.1413%
-40.8725%
-19.7451%
-20.7358%
37.1121%
36.7618%
18.0521%
15.1496%
11.9422%
13.7258%
15.0299%
18.9505%
150.8558%
192.222%
789.0596%
8.8411%
-301.8512%
-212.4933%
-114.1441%
-4.3186%
-10.7507%
-9.1013%
2.788%
7.5574%
1.7193%
6.2262%
6.8659%
-1.9694%
5.2752%
7.4521%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.